Skip to main content
. 2013 Feb 13;6:14. doi: 10.1186/1757-2215-6-14

Table 1.

Patient characteristics of the present study population

Characteristic No. of patients (%)
Median age, years (range)
58.6 (23.5–89.2)
Median CA-125 level at diagnosis, U/ml (range)
490.5 (7–33439)
Median nadir CA-125 level, U/ml (range)
10 (4–35)
Ethnicity
 
 White
316 (77.1)
 Black
25 (6.1)
 Hispanic
56 (13.7)
 Other*
13 (3.2)
Histology
 
 Serous
317 (77.3)
 Endometrioid
42 (10.2)
 Clear cell
18 (4.4)
 Mucinous
9 (2.2)
 Transitional
6 (1.5)
 Undifferentiated
9 (2.2)
 MMMT
9 (2.2)
Grade
 
 High
361 (88.0)
 Low
49 (12.0)
FIGO stage
 
 I
42 (10.2)
 II
31 (7.6)
 III
284 (69.3)
 IV
53 (12.9)
Residual disease after primary surgery
 
 Optimal ( 1 cm)
322
 Suboptimal (> 1 cm)
65
 Unknown
23
NACT
 
 Yes
46 (11.2)
 No
354 (86.3)
 Unknown 10 (2.4)

Note: All data are no. of patients (%) unless noted otherwise.

Abbreviations: MMMT, malignant mixed müllerian tumor; FIGO, International Federation of Gynecology and Obstetrics; NACT, Neoadjuvant chemotherapy.

*5 Chinese, 4 Middle Eastern, 1 Japanese, 1 Korean, and 2 Indian patients.